Investor’s Delight: Palisade Bio Inc (PALI) Closes Weak at 3.75, Down -12.08

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Palisade Bio Inc (NASDAQ: PALI) was $3.75 for the day, down -12.08% from the previous closing price of $4.26. In other words, the price has decreased by -$12.08 from its previous closing price. On the day, 1.66 million shares were traded. PALI stock price reached its highest trading level at $4.65 during the session, while it also had its lowest trading level at $3.66.

Ratios:

Our analysis of PALI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 4.84. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 28 ’24 when Williams Donald Allen bought 1,000 shares for $4.86 per share. The transaction valued at 4,863 led to the insider holds 1,000 shares of the business.

Finley John David bought 1,000 shares of PALI for $4,810 on May 24 ’24. The CEO, CFO, Director now owns 8,437 shares after completing the transaction at $4.81 per share. On Feb 06 ’24, another insider, Finley John David, who serves as the CEO, CFO, Director of the company, bought 10,000 shares for $0.47 each. As a result, the insider paid 4,692 and bolstered with 84,649 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 3511507 and an Enterprise Value of -7575142.

Stock Price History:

Over the past 52 weeks, PALI has reached a high of $35.40, while it has fallen to a 52-week low of $3.82. The 50-Day Moving Average of the stock is -20.16%, while the 200-Day Moving Average is calculated to be -44.57%.

Shares Statistics:

PALI traded an average of 255.70K shares per day over the past three months and 230460 shares per day over the past ten days. A total of 0.94M shares are outstanding, with a floating share count of 0.91M. Insiders hold about 2.30% of the company’s shares, while institutions hold 6.62% stake in the company. Shares short for PALI as of 1721001600 were 54577 with a Short Ratio of 0.21, compared to 1718323200 on 27119. Therefore, it implies a Short% of Shares Outstanding of 54577 and a Short% of Float of 5.89.

Earnings Estimates

The company has 2.0 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$2.93 for the current quarter, with a high estimate of -$2.75 and a low estimate of -$3.11, while EPS last year was -$7.95. The consensus estimate for the next quarter is -$2.48, with high estimates of -$2.26 and low estimates of -$2.7.

Analysts are recommending an EPS of between -$10.81 and -$12.5 for the fiscal current year, implying an average EPS of -$11.65. EPS for the following year is -$8.81, with 2.0 analysts recommending between -$3.54 and -$14.08.

Most Popular